Clin2
NCT04520217Possibly a fitRecruiting

Topical imipramine for skin UVB light sensitivity

PhotosensitivityMicrovesicle Particle

Part of Skin clinical trials.

This Phase 1 study tests whether a cream called imipramine can reduce tiny UVB-triggered skin “microvesicles” in people who are sensitive to sunlight. The goal is to see if the cream is safe and may lessen harmful skin reactions from UVB exposure.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You’re age 18 to 50 and can sign consent
  • You identify yourself as having light/sun sensitivity
  • You can reliably get to the study site and appointments (stable transportation)
  • You can list your medicines and avoid known light-sensitizing drugs
  • You cannot be pregnant, trying to conceive, or breastfeeding if you’re female
  • You cannot use or have used tanning beds or UVB/photodynamic treatments recently

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05688904Recruiting· Phase 1
Topical imipramine with light treatment for skin pain relief

This Phase 1 study tests whether applying imipramine cream to the skin affects pain and effectiveness when combined with a light-based skin treatment (photodynamic therapy). It’s mainly looking at safety and early signs of benefit for people with certain sun-damaged skin areas.

Fairborn, Ohio
NCT06778434Recruiting· Phase 2
Using a cream to improve light therapy for veterans' sun-damaged skin

This trial tests whether adding a cream called imipramine to standard photodynamic therapy (light treatment) can reduce the immune suppression that sometimes happens after the therapy. It may help veterans with sun-damaged skin on their forearms or face.

Dayton, Ohio
NCT06312813Recruiting· Phase 2
Testing antidepressant creams for rosacea redness

This study tests if creams containing two antidepressants (imipramine and amitriptyline) can reduce skin redness caused by UV light in people with rosacea. It compares how the creams affect redness to see if they could be a new treatment option.

Fairborn, Ohio
NCT07640061Not yet recruiting· Phase 1
Testing amitriptyline for burn injury treatment

This study tests whether a common medication called amitriptyline can help reduce inflammation after a burn injury. It may help the body heal better and reduce pain.

Fairborn, Ohio
NCT07716722Not yet recruiting· Phase 1
Testing a numbing cream to help skin heal after small cuts

This study tests whether a numbing cream with amitriptyline can help skin heal better after small cuts. It may reduce scarring or improve healing.

Fairborn, Ohio
NCT07795866Not yet recruiting
Skin brightening creams for sun-tanned skin

This study tests whether different cosmetic creams can brighten skin after it's been exposed to UV light. If you're healthy and your skin tone fits, you may be able to join this short-term trial.

Hear when a new Photosensitivity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.